CoinDCX recently announced raising $20,000,000 in funding. As India's premier Crypto Investment App, CoinDCX continues to revolutionize the crypto space by offering a secure and user-friendly platform. With a wide range of crypto-based financial products and services supported by top-notch security processes and insurance, CoinDCX has become the go-to exchange for over 1.3 crore users, boasting a listing of 200+ coins. The funding will further propel CoinDCX's mission to address challenges faced by the Indian crypto community, enhance crypto investing and trading opportunities, and promote crypto literacy. With a winning aggregation model that ensures peak liquidity from top global exchanges, CoinDCX is at the forefront of the industry, with the backing of esteemed investors such as Polychain Capital, Coinbase Ventures, Bain Capital Ventures, and BitMEX's operator, the HDR Group.
CoinDCX Secures $20M in Series B Funding to Revolutionize Cryptocurrency Investing in India
Recently funded 路 $20.0M Series bCryptocurrency
Get the full CoinDCX company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
